Viewing Study NCT02362620

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-02-25 @ 6:43 PM
Study NCT ID: NCT02362620
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2015-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Prostate Cancer View
None Cabazitaxel View
None Docetaxel View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic Castration Resistant Prostate Cancer View
None Taxanes View
None Biomarkers View